Northeast Investment Management Has $4.90 Million Position in Colgate-Palmolive (NYSE:CL)

Northeast Investment Management increased its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 2.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,948 shares of the company’s stock after purchasing an additional 1,188 shares during the period. Northeast Investment Management’s holdings in Colgate-Palmolive were worth $4,904,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Hager Investment Management Services LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at about $36,000. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $42,000. Synergy Asset Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth $49,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $53,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 1.3 %

Shares of Colgate-Palmolive stock opened at $86.81 on Friday. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The business has a 50-day moving average price of $90.36 and a 200-day moving average price of $96.76. The firm has a market cap of $70.93 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 earnings per share. Equities research analysts anticipate that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analysts Set New Price Targets

CL has been the subject of a number of analyst reports. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Finally, Morgan Stanley reduced their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $101.16.

Get Our Latest Stock Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.